Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGNYZ) Return on Assets (2016 - 2025)

Historic Return on Assets for Ligand Pharmaceuticals (LGNYZ) over the last 13 years, with Q3 2025 value amounting to 0.04%.

  • Ligand Pharmaceuticals' Return on Assets changed N/A to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year change of. This contributed to the annual value of 0.0% for FY2024, which is 0.0% changed from last year.
  • Per Ligand Pharmaceuticals' latest filing, its Return on Assets stood at 0.04% for Q3 2025.
  • Over the past 5 years, Ligand Pharmaceuticals' Return on Assets peaked at 0.04% during Q3 2025, and registered a low of 0.08% during Q1 2025.
  • Over the past 5 years, Ligand Pharmaceuticals' median Return on Assets value was 0.02% (recorded in 2021), while the average stood at 0.02%.
  • Per our database at Business Quant, Ligand Pharmaceuticals' Return on Assets surged by 700bps in 2021 and then plummeted by -400bps in 2022.
  • Ligand Pharmaceuticals' Return on Assets (Quarter) stood at 0.01% in 2021, then plummeted by -108bps to 0.03% in 2022, then soared by 93bps to 0.0% in 2023, then plummeted by -1432bps to 0.03% in 2024, then skyrocketed by 222bps to 0.04% in 2025.
  • Its Return on Assets was 0.04% in Q3 2025, compared to 0.07% in Q2 2025 and 0.08% in Q1 2025.